Based on research presented by Dr. Russell A. Barkley · PESI ADHD Summit, November 2022
There is a belief, rarely spoken aloud but deeply felt, that the important conversations can wait. That the harder, more honest engagement with what is truly happening — with a child’s struggles, with a diagnosis deferred, with a treatment abandoned — can be revisited later, when things settle. This belief feels protective. But it compounds distance. And in the case of ADHD, the research now tells us plainly: time is not a neutral resource.
At the 2022 PESI ADHD Summit, Dr. Russell Barkley offered not a lecture on failure but an invitation to clarity. His findings on ADHD’s impact on life expectancy are not meant to provoke panic. They are meant to surface what matters — so that those living with ADHD, and those caring for them, might choose more deliberately.
A disorder of time, not just attention.
Barkley’s central reframe is this: ADHD is not primarily a disorder of attention. It is a disorder of self-regulation — and at its deepest root, a disorder of time. People with ADHD perceive and prepare for the future roughly 30–40% less than their peers. The further ahead a consequence lies, the less weight it carries. This is not a character flaw. It is a neurological reality with real and cumulative consequences.
Across hundreds of daily decisions — what to eat, whether to rest, how much to drink, whether to follow through on care — that compressed horizon shapes a life. Not in any single moment, but quietly, over the years.
Healthy life lost (persistent ADHD) vs. general population: 13 years
Early mortality risk by midlife: 4-5x higher than neurotypical adults
Annual cost per patient in health & related costs: $26,000
What the numbers ask of us.
Barkley’s Milwaukee Longitudinal Study, which followed children with ADHD into adulthood and applied an actuarial life expectancy algorithm, found that adults with persistent ADHD lost nearly 13 years of healthy life compared to controls. Those whose symptoms no longer met diagnostic thresholds still lost 7.5 years. The disorder, even when quieter, leaves a mark.
These numbers are not presented here to alarm. They are presented because awareness is where deliberate action begins. Obesity reduces lifespan by roughly 4 years. Smoking, 2 to 6 years. High blood pressure, 5 years. ADHD, untreated, exceeds all of them. And yet it remains the condition least likely to be screened for in primary care, least likely to be treated through adulthood, and most likely to be minimized in conversation.
“ADHD is a serious public health disorder. Far worse than all the things our government and healthcare industry worry about with regard to lifespan — and we are not spending billions of dollars to do anything about it.”— Dr. Russell A. Barkley
The risk factors are modifiable. The window is open.
What makes this research grounding rather than despairing is this: the vast majority of the factors driving reduced life expectancy in ADHD can be changed. Exercise, diet, sleep, substance use, driving behavior, sustained treatment — these are not fixed destinies. They are choices that become more available when the underlying disorder is recognized and supported.
Sustained medication has been shown in population-wide studies to reduce accidents, obesity, teenage pregnancy, substance use, and suicide. But the barrier is not treatment itself — it is continuity. By age 21, only one in ten people with ADHD remained in any treatment program. Barkley draws the comparison simply: stopping ADHD treatment is no different from stopping insulin for diabetes. The disorder returns. So do the risks.
The invitation here is not urgent in the anxious sense. It is presence in the deliberate sense — to see clearly what is happening, to name it honestly, and to act in alignment with what matters while the opportunity remains. For families, that may mean asking harder questions sooner. For clinicians, it may mean widening the lens. For anyone who has been waiting for a better moment to engage — with a diagnosis, a conversation, or a return to care — this research gently suggests: the better moment is now.
The latest evidence confirms the same truth.
Barkley’s findings have since been independently confirmed at a population scale. A landmark 2025 matched-cohort study drawing on UK primary care data from more than 9.5 million people reached the same conclusion — not as a verdict, but as a call for what is still possible.
Study conclusion
“Adults with diagnosed ADHD are living shorter lives than they should. We believe that this is likely caused by modifiable risk factors and unmet support and treatment needs in terms of both ADHD and co-occurring mental and physical health conditions.”
O’Nions et al. (2025). British Journal of Psychiatry, 226(5), 261–268. doi:10.1192/bjp.2024.199
The word that carries the most weight in that conclusion is modifiable. The distance between the lives people with ADHD are living and the lives they could be living is not set in stone. It is a product of what has gone unrecognized, unsupported, and unaddressed. That gap can be closed — not all at once, but with clarity, consistency, and the willingness to begin.
Stormy copyright Leilani Norman
Leilani M Norman 
Leave a comment